FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Medtronic Safety Notice on Imaging System

Medtronic issues an urgent field safety notice about the potential for navigational inaccuracy when its O-arm O2 Imaging Systems auto-registration fea...

Human Drugs

Fusion IV Recalls Sterile Drug Products

Fusion IV Pharmaceuticals (dba Axia Pharmaceutical) recalls all unused sterile drug products within expiry due to a lack of sterility assurance.

Human Drugs

House Members Seek FDA Info on Complex Generics

Bipartisan House Energy and Commerce Committee ask FDA to provide information on the agencys approval performance on complex generic drugs, saying the...

Human Drugs

TG Therapeutics Rolling NDA for Lymphoma Drug

TG Therapeutics begins a rolling NDA submission for umbralisib, a dual inhibitor of PI3K-delta and CK1-epsilon for treating patients with previously t...

Federal Register

Info Collection Extension for BLA Licensing Provsions

Federal Register notice: FDA submits to OMB an information collection extension for BLA general licensing provisions.

Medical Devices

FDA Electronic Product Certification Program Explained

CDRH electrical engineer Lowell Howard explains in a CDRH Learn video how manufacturers and importers can comply with the FDA electronic product radia...

Medical Devices

Workshop on Medical Extended Reality Devices

FDA sets a 3/5 public workshop entitled Medical Extended Reality: Toward Best Evaluation Practices for Virtual and Augmented Reality in Medicine.

Human Drugs

Mindbreeze Works with Booz Allen on CDER Project

Mindbreeze says it is working with Booz Allen to give CDER regulatory review search capabilities.

Human Drugs

Arena Gains Fast Track for Heart Failure Drug

FDA grants Arena Pharmaceuticals a fast track designation for APD418, a β3-adrenergic receptor antagonist and cardiac myotrope for treating decom...

Human Drugs

FDA Denies Otsuka Samsca Petition

FDA denies an Otsuka petition asking that it determine that the companys Samsca was withdrawn for reasons of safety and that no generic forms of the d...